Paul Hartmann logo

Paul Hartmann

Stock
Stock
ISIN: DE0007474041
Ticker: PHH2
DE0007474041
PHH2

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Paul Hartmann has so far distributed $9.377 in 2026. The next dividend will be paid on 05.05.2027


$7.298

CHART BY

Frequently asked questions

The market capitalization of Paul Hartmann is $823.02M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Paul Hartmann is 7.11. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Paul Hartmann's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $32.58. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Paul Hartmann's stock, with a consensus target price of . Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Paul Hartmann reported a revenue of $2.88B.
Paul Hartmann's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $323.46M. EBITDA measures the company's overall financial performance.
Paul Hartmann employs approximately 10,066 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Paul Hartmann is 1.10M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$823.02M
EPS (TTM) 
$32.58
Free Float 
1.10M
P/E ratio (TTM) 
7.11
Revenue (TTM) 
$2.88B
EBITDA (TTM) 
$323.46M

Pricing

1D span
$233.71$238.74
52W span
$226.27$275.55

Analyst Ratings

The price target is and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through the following segments: Wound Management, Incontinence Management, Infection Management, and Other Group Activities. The Wound Management segment includes wound dressing and products for compression therapy and immobilization. The Incontinence Management segment provides incontinence hygiene, medical records, and products for patients and medical skin care. The Infection Management segment consists of surgery sets, surgical clothing, and surgical examination gloves. The Other Group Activities segment focuses on the areas of cotton wool products, feminine hygiene, baby hygiene, medical consumer goods, medicated and dietary supplements, body care and bath products, and commercial business. The company was founded in 1818 and is headquartered in Heidenheim, Germany.

Employees
10,066
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
DE0007474041
Primary Ticker
PHH2

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation